Leukemia after therapy with methyl CCNU.
D001932:Brain Neoplasms / Q000188:drug therapy; D005260:Female; D005625:Frontal Lobe; D006801:Humans; D007938:Leukemia / Q000139:chemically induced*; D007948:Leukemia, Monocytic, Acute / Q000139:chemically induced; D015470:Leukemia, Myeloid, Acute / Q000139:chemically induced; D008875:Middle Aged; D009607:Nitrosourea Compounds / Q000009:adverse effects*; D009837:Oligodendroglioma / Q000188:drug therapy; D010198:Pancytopenia / Q000139:chemically induced; D012673:Semustine / Q000009:adverse effects*
D009607:Nitrosourea Compounds; D012673:Semustine